(Q34341579)

1 August 2017

1 reference

title

Present and future of veterinary viral vaccinology: a review (English)

1 reference

1 August 2017

van Oirschot JT

1

1 reference

1 August 2017

language of work or name

1 reference

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

23

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

100-108

1 reference

A competitive ELISA for the detection of anti-tubule antibodies using a monoclonal antibody against bluetongue virus non-structural protein NS1.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Immunization of animals: from DNA to the dinner plate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Expression of the nonstructural protein NS1 of equine influenza A virus: detection of anti-NS1 antibody in post infection equine sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Oral vaccination of the fox against rabies using a live recombinant vaccinia virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Genetic manipulation of non-segmented negative-strand RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

The computation of R0 for discrete-time epidemic models with dynamic heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Experimental quantification of vaccine-induced reduction in virus transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

A century of veterinary vaccinology: the Mérieux initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Prevention of transplacental transmission of moderate-virulent classical swine fever virus after single or double vaccination with an E2 subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Aujeszky's disease virus eradication campaign successfully heading for last stage in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Comparative studies of the efficacy of a recombinant feline leukaemia virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Expression in baculovirus vector system of the nucleocapsid protein gene of rinderpest virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Cell-mediated immunity to pseudorabies virus: cytolytic effector cells with characteristics of lymphokine-activated killer cells lyse virus-infected and glycoprotein gB- and gC-transfected L14 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

21 January 2018

DNA vaccines: a review

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Non-replicating expression vectors: applications in vaccine development and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

A gE-negative BHV1 vaccine virus strain cannot perpetuate in cattle populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Development of a classical swine fever subunit marker vaccine and companion diagnostic test

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Negative-strand RNA viruses: genetic engineering and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Construction and characterization of deletion mutants of pseudorabies virus: a new generation of 'live' vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

The prime-boost strategy: exciting prospects for improved vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Give us this day our daily germs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Protective immune correlates can segregate by vaccine type in a murine herpes model system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Detection of antibodies against porcine parvovirus nonstructural protein NS1 may distinguish between vaccinated and infected pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Induction of antibodies to glycoprotein I in pigs exposed to different doses of a mildly virulent strain of Aujeszky's disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Diva vaccines that reduce virus transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Vaccination of cattle against bovine viral diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

A DNA vaccine coding for glycoprotein B of pseudorabies virus induces cell-mediated immunity in pigs and reduces virus excretion early after infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Nucleic acids: vaccines of the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

Skin immunization made possible by cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.2001.9695094

10.1080/01652176.2001.9695094

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference